4.4 Article

The substantial loss of H3K27me3 can stratify risk in grade 2, but not in grade 3 meningioma

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma

Kulandaimanuvel Antony Michealraj et al.

Article Clinical Neurology

Prognostic Value of Histopathological Features and Loss of H3K27me3 Immunolabeling in Anaplastic Meningioma: A Multicenter Retrospective Study

Guillaume Gauchotte et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2020)

Review Pathology

Molecular characteristics of meningiomas

Young Suk Lee et al.

JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2020)

Article Clinical Neurology

Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence

Leah M. Katz et al.

ACTA NEUROPATHOLOGICA (2018)

Review Oncology

BAP1 mutations in high-grade meningioma: implications for patient care

Ganesh M. Shankar et al.

NEURO-ONCOLOGY (2017)

Review Biochemistry & Molecular Biology

Writing, erasing and reading histone lysine methylations

Kwangbeom Hyun et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2017)

Article Oncology

TERT Promoter Mutations and Risk of Recurrence in Meningioma

Felix Sahm et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)

Article Oncology

TERT Promoter Mutations and Risk of Recurrence in Meningioma

Felix Sahm et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)

Review Oncology

EANO guidelines for the diagnosis and treatment of meningiomas

Roland Goldbrunner et al.

LANCET ONCOLOGY (2016)

Article Multidisciplinary Sciences

Epigenomic alterations define lethal CIMP-positive ependymomas of infancy

S. C. Mack et al.

NATURE (2014)

Article Genetics & Heredity

Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer

Yeshayahu Schlesinger et al.

NATURE GENETICS (2007)